Huons Obtains US FDA Generic Approval for '1% Ricadoin Injection'
[Asia Economy Reporter Minji Lee] Huons announced on the 8th that its 1% lidocaine injection vial product has been proven to be biologically equivalent to the reference drug Fresenius Kabi's Xylocaine Injection 1%, and has obtained product approval.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
